WO2023173181 - STRAIN AND A BIFIDOBACTERIAL PREPARATION HAVING HYPOLIPIDEMIC, ANTI-INFLAMMATORY IMMUNOMODULATING AND INSULIN RESISTANCE DECREASING EFFECTS

National phase entry:
Publication Number WO/2023/173181
Publication Date 21.09.2023
International Application No. PCT/BG2023/000009
International Filing Date 16.03.2023
Title **
[English] STRAIN AND A BIFIDOBACTERIAL PREPARATION HAVING HYPOLIPIDEMIC, ANTI-INFLAMMATORY IMMUNOMODULATING AND INSULIN RESISTANCE DECREASING EFFECTS
[French] ET UNE PRÉPARATION BIFIDOBACTÉRIENNE PRÉSENTANT DES EFFETS HYPOLIPIDÉMIQUES, ANTI-INFLAMMATOIRES, IMMUNOMODULATEURS ET DIMINUANT LA RÉSISTANCE À L'INSULINE
Applicants **
LB BULGARICUM EAD
Inventors
DIMITROV, Zhechko Panayotov
GOTOVA, Irina Marinova
MICHAYLOVA, Michaela Lyubomirova
PASHOVA-BALTOVA, Kalinka Nikolova
URSHEV, Zoltan Lubomirov
Priority Data
113505   18.03.2022   BG
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1880
EPO Filing, Examination, Granting8126
Japan Filing, Examination, Granting2001
South Korea Filing, Examination, Granting1757
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 18,504

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] 3/15 NBIMCC 9085 and the bifidobacterial preparation for the prevention and therapy of atherosclerosis, cardiovascular and inflammatory diseases and to reduce the diabetes risk.[French] 3/15 NBIMCC 9085 et de la préparation bifidobactérienne pour la prévention et la thérapie de l'athérosclérose, des maladies cardiovasculaires et inflammatoires et pour réduire le risque de diabète.